|
|
||||||||
a Division of Cardiothoracic and Vascular Surgery, Department of Surgery, Brody School of Medicine, East Carolina University, Greenville, North Carolina
b Division of Cardiology, Department of Medicine, Brody School of Medicine, East Carolina University, Greenville, North Carolina
c Department of Biostatistics, Brody School of Medicine, East Carolina University, Greenville, North Carolina
Accepted for publication April 30, 2007.
* Address correspondence to Dr Rodriguez, Division of Cardiothoracic and Vascular Surgery, East Carolina University, 600 Moye Blvd, Teaching Annex #257, Greenville, NC 27858 (Email: rodrigueze{at}ecu.edu).
Presented at the Fifty-third Annual Meeting of the Southern Thoracic Surgical Association, Tucson, AZ, Nov 8–11, 2006.
Background: Centers have expanded indications for robotic mitral valve repairs to include complex pathologic features. We studied our results after robotic mitral valve repair for anterior leaflet or bileaflet prolapse.
Methods: Data were collected contemporaneously on 289 patients operated on from May 2000 to September 2006. Every patient underwent preoperative transesophageal echocardiography. Follow-up consisted of serial echocardiograms, clinic visits, and phone conversations with patients and their physicians.
Results: A total of 66 patients (anterior leaflet, n = 14; and bileaflet, n = 52) were identified. Mean age was 52.6 ± 7.1 years, and 57 (86%) patients had New York Heart Association functional class II or III symptoms. Cardiopulmonary bypass and cross-clamp times were 171 ± 52 and 132 ± 39 minutes, respectively. The 30-day and late mortality rates were 3% (n = 2) for each time point. There were no device-related or perfusion-related complications or sternotomy conversions. Complications included 2 strokes (3%), 2 bleeding reexplorations (3%), and 10 pleural effusions requiring intervention (15%). The length of hospital stay for surviving patients was 5 ± 3 days, and time to extubation averaged 9.5 ± 13 hours. A total of 6 (9%) patients required valve reoperation. Mean follow-up was 795 ± 495 days, and echocardiographic mitral regurgitation (n = 60) was none or trace (n = 35, 58.3%), mild (n = 19, 31.6%), moderate (n = 2, 3.3%), and severe (n = 4, 6.7%).
Conclusions: Robotic mitral valve repair for anterior leaflet and bileaflet prolapse is feasible and safe. Outcomes and degree of late mitral regurgitation are similar to series using conventional techniques. Long-term follow-up is required to formally address the efficacy of robotic repair techniques.
This article has been cited by other articles:
![]() |
J. G. Castillo, A. C. Anyanwu, A. El-Eshmawi, and D. H. Adams All anterior and bileaflet mitral valve prolapses are repairable in the modern era of reconstructive surgery Eur J Cardiothorac Surg, April 26, 2013; (2013) ezt196v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ibrahim, C. Rao, and T. Athanasiou Artificial chordae for degenerative mitral valve disease: critical analysis of current techniques Interact CardioVasc Thorac Surg, December 1, 2012; 15(6): 1019 - 1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Chan, M. Ruel, S. Chaudry, S. Lambert, and T. G. Mesana Clinical and echocardiographic outcomes after repair of mitral valve bileaflet prolapse due to myxomatous disease J. Thorac. Cardiovasc. Surg., April 1, 2012; 143(4_suppl): S8 - S11. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Suri, H. M. Burkhart, R. C. Daly, J. A. Dearani, S. J. Park, T. M. Sundt III, Z. Li, M. Enriquez-Sarano, and H. V. Schaff Robotic mitral valve repair for all prolapse subsets using techniques identical to open valvuloplasty: Establishing the benchmark against which percutaneous interventions should be judged J. Thorac. Cardiovasc. Surg., November 1, 2011; 142(5): 970 - 979. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Speziale, G. Nasso, G. Esposito, M. Conte, E. Greco, K. Fattouch, F. Fiore, M. Del Giglio, R. Coppola, and L. Tavazzi Results of mitral valve repair for Barlow disease (bileaflet prolapse) via right minithoracotomy versus conventional median sternotomy: A randomized trial J. Thorac. Cardiovasc. Surg., July 1, 2011; 142(1): 77 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Modi, E. Rodriguez, and W. R. Chitwood Jr. Robot-assisted cardiac surgery Interact CardioVasc Thorac Surg, September 1, 2009; 9(3): 500 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Umakanthan, M. Leacche, M. R. Petracek, S. Kumar, N. V. Solenkova, C. A. Kaiser, J. P. Greelish, J. M. Balaguer, R. M. Ahmad, S. K. Ball, et al. Safety of Minimally Invasive Mitral Valve Surgery Without Aortic Cross-Clamp Ann. Thorac. Surg., May 1, 2008; 85(5): 1544 - 1550. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |